Press release
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis - Woman in s Chittagong slum, Bangladesh
March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per year as COVID-19. Last year, tuberculosis killed 1.4 million people.
Tuberculosis or TB, occurs all around the world, but in 2019 a mere 30 countries accounted for 87% of new TB cases. Of these, eight countries accounted for two thirds of the total: India, Indonesia, China, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa.
Roughly 12 million people are infected by tuberculosis per year. These are frequently people living in impoverished conditions in high population density areas. While getting ill is extremely easy in these conditions, getting a diagnosis is proportionally difficult. Tuberculosis treatment is not cheap affair. Although in many high-burden countries first-line medications are free or heavily discounted, transportation to get to health centers or well-balanced meals are not.
10% of patients will develop resistance to the first-line drugs and treatment for drug-resistant TB can be far more painstaking. Frequently these drugs are not fully subsidized, putting them out of reach of people who cannot afford them but depend on them to be cured.
Help us support people in need. With your help we can provide access to diagnostics and essential medicines to those who need it.
Noordwal 10
2513EA The Hague
Netherlands
Register ID (KvK) 78242622
Contact: info@woidmo.org
The World Infectious Disease Monitoring Organization (WoIDMo) is an NGO, that brings together a network of infectious disease specialists and individuals from around the world.
Our mission is to provide practical humanitarian aid to relieve the burden of infectious diseases, enhancing preparedness through programs that offer immediate help.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release World Tuberculosis Day - Tuberculosis, the invisible pandemic here
News-ID: 2260514 • Views: …
More Releases for Tuberculosis
Revolutionizing the Fight Against Tuberculosis: Global Anti-Tuberculosis Therape …
The global Anti-Tuberculosis (TB) Therapeutics Market is on the cusp of a transformative era, driven by urgent medical need, groundbreaking scientific advances, and expanding public-private partnerships. With an estimated 10 million new TB cases reported worldwide in 2022 and 1.4 million deaths, tuberculosis remains a leading infectious disease killer, commanding critical attention from healthcare providers, governments, and pharmaceutical innovators alike. As the world rallies to eliminate this centuries-old scourge, the…
Latent Tuberculosis Infection Detection Market
Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research…
Tuberculosis (TB) Diagnostics Market - Detect, Diagnose, Defeat: Innovating Solu …
Newark, New Castle, USA - new report, titled Tuberculosis (TB) Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tuberculosis (TB) Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tuberculosis (TB) Diagnostics market. The report offers an overview of…
Conquering Tuberculosis: Exploring the Innovations in Mycobacterium Tuberculosis …
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast period 2022-2032.
Mycobacterium tuberculosis is a bacteria that causes tuberculosis (TB), which mostly affects the lungs. Tuberculosis is a major public health crisis concern; however, it can be cured and prevented. Adults are most often affected by tuberculosis during their most productive years. Over…
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Ocular tuberculosis is a type…
Tuberculosis Testing Market to Increasing Tuberculosis Awareness and Control Pro …
A new Transparency Market Research report states that the global tuberculosis testing market stood at US$1.9 bn in 2013 and is predicted to reach US$2.6 bn by 2020. It is predicted to expand at a CAGR of 4.30% from 2014 to 2020. The title of the report is “Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.”
As per the report, the rising acceptance…
